cholesteryl

Cholesteryl Hemisuccinate (Cholesterol hydrogen succinate) is a highly soluble cholesterol analogue often used in polar solutions for its hepatoprotective, anticancer and tumour growth inhibiting properties. Cholesteryl Hemisuccinate inhibits the hepatotoxicity of acetaminophen and prevents AAP-induced apoptosis and necrosis in hepatocytes. Cholesteryl Hemisuccinate inhibits DNA polymerase and DNA topoisomerase, thereby inhibiting DNA replication and repair as well as cell division.

Cholesteryl palmitic acid is a cholesteryl ester. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination of steroid and alcohol) and a lipid found in the cell membranes of all body tissues and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides).

Torcetrapib (CP-529414) is a cholesteryl ester transfer protein (CETP) inhibitor designed to reduce the heterotypic transfer of cholesteryl ester from HDL to LDL and/or VLDL. It failed in phase III trials due to an excess of deaths.

Cholesteryl Acetate is a cholesterol ester obtained from the esterification of the hydroxyl group of cholesterol with acetic acid. It functions as a metabolite in the human body and is both a cholesterol ester and an acetate ester.

Cholesteryl linoleate is the major cholesteryl ester in LDL and atherosclerotic lesions. It is present in LDL as a cholesteryl ester that is oxidized to form cholesteryl linoleate hydroperoxides using LDL receptor-associated proteins that are transferred to the plasma membranes of macrophages and CHO cells expressing 15-lipoxygenase.

Cholesteryl sulfate sodium (Sodium Cholesteryl Sulfate) is a sterol sulfate in human plasma. Cholesteryl sulfate sodium is a component of cell membrane and has a regulatory function. Cholesteryl sulfate sodium also activates multiple protein kinase C (PKC) iso-enzymes, especially the ε, η and ζ isoforms.

Cholesteryl formate (3beta-Acetoxy-cholest-5-ene), the first compounds to be isolated from red algae, is a cholesteryl ester.

Cholesteryl arachidonate is a human endogenous metabolite.

Cholesteryl Linolenate is a human endogenous metabolite.

Cholesteryl behenate is a standard in electrospray ionization tandem mass spectrometry for the analysis of cholesteryl esters and cholesterol.

Cholesteryl oleate (Cholesteryl cis-9-octadecenoate) is a cholesteryl ester. Cholesteryl oleate can be used to synthesize solid lipid nanoparticles which is a nanoparticle-based gene therapy approach.

Cholesteryl Laurate is a cholesterol ester widely used in biochemical experiments and drug synthesis research.

(±)13-HODE cholesteryl ester, initially extracted from atherosclerotic lesions, is produced via Cu2+-catalyzed oxidation of LDL. Subsequent studies revealed that 15-LO from rabbit reticulocytes and human monocytes could metabolize cholesteryl linoleate (a major LDL component) to 13-HODE cholesteryl ester.

(±)9-HODE cholesteryl ester, initially extracted from atherosclerotic lesions, is formed through Cu2+-catalyzed oxidation of LDL. Subsequent research demonstrated that 15-LO from rabbit reticulocytes and human monocytes can metabolize cholesteryl linoleate, a major LDL component, into 9-HODE cholesteryl ester.

9(R)-HODE cholesteryl ester, originally extracted from atherosclerotic lesions, has an oxidized fatty acid portion that may result from either enzymatic lipoxygenation or random lipid peroxidation. It serves as a standard for analyzing chiral HODE cholesteryl esters.

13(R)-HODE cholesteryl ester was originally extracted from atherosclerotic lesions. It remains uncertain whether the oxidized fatty acid portion of the molecule results from enzymatic lipoxygenation or from random lipid peroxidation. 13(R)-HODE cholesteryl ester can be used as a standard for analysis of chiral HODE cholesteryl esters.

9(S)-HODE cholesteryl ester, originally extracted from atherosclerotic lesions, has an uncertain origin of its oxidized fatty acid portion, which may result from either enzymatic lipoxygenation or random lipid peroxidation. This compound can be used as a standard for analyzing chiral HODE cholesteryl esters.

Cholesteryl heptadecanoate is a cholesterol ester (CE) formed by the condensation of cholesterol with heptadecanoic acid, a C-17 saturated fatty acid that does not occur in any natural animal or vegetable fat at high concentrations. As such, it is commonly used as an internal standard for the quantification of cholesterol esters by GC- or LC-mass spectrometry. CEs are major constituents of lipoprotein particles carried in blood and accumulate in the fatty acid lesions of atherosclerotic plaques. CEs of various fatty acids are major constituents of murine and human adrenal glands.

Cholesteryl Lignocerate is a cholesterol ester that can be hydrolysed by acid lipases.

Cholesteryl homo-γ-linolenate, a cholesterol ester, accumulates in the adrenal gland of rabbits on a linolenic acid-rich diet. In HIV-infected humans, levels of cholesteryl homo-γ-linolenate decrease and positively correlate with cognitive decline.

Cholesteryl arachidate is a cholesterol ester that has been found in human meibum.[1][2] It has been used as an internal standard for the quantification of fatty acids in B. napus.[3]

Cholesteryl erucate, a cholesterol ester, serves as a standard for the quantification of cholesterol esters in human meibomian gland secretions.

Cholesteryl chloride is a useful organic compound for research related to life sciences. The catalog number is T65074 and the CAS number is 910-31-6.

Cholesteryl docosapentaenoate, a cholesterol ester, exhibits increased levels in the liver, plasma, and skeletal muscle of acyl-CoA binding protein (ACBP) knockout mice relative to homozygous controls.